Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Welcome Prof Shelley McKeown Jones

Research Highlights Strategic Developments

Fellow and Tutor in Experimental Psychology with Lady Margaret Hall joining us from Bristol

Farewell to the Le Gros Clark Building

Strategic Developments

We say goodbye to a building that has been central through our development as DPAG

Launch of innovative new study to tackle mental health inequalities

Research Highlights Strategic Developments

An innovative new study working with diverse people living with psychosis and other long-term physical health conditions.

Brain Health Innovation Summit

Events Strategic Developments

Where expertise meets innovation:a taskforce driving brain health research

Professor David M Clark joins Oxford Health as Non-Executive Director

Awards and Honours Strategic Developments

The Emeritus Professor of Experimental Psychology took up his role on 17 July 2023.

University of Oxford and Selvita collaborate to advance potential therapeutics for Parkinson's Disease

Strategic Developments

The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease

Brain and mental health innovation at Oxford

Research Highlights Strategic Developments

Mental Health and Dementia are a global healthcare crisis, affecting over one billion people worldwide. Of those, over 400 million people are on the Alzheimer's disease continuum, with one person diagnosed every three seconds, and the figure expected to rise as the global population of those over 60 is set to double by 2050.

Experts hold first meeting for new international project on depression, anxiety and psychosis

Strategic Developments

The Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis, or GALENOS project, has launched in central London.

Ensuring LGBTQI+ people are treated fairly in mental health data

Research Highlights Strategic Developments

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.

Life and Mind Building construction tops out

Events Strategic Developments

Another milestone was reached this week with the topping out ceremony of the new Life and Mind Building.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

Research Highlights Strategic Developments

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

Director of MRC Brain Network Dynamics Unit appointed

Strategic Developments

From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.

Oxford gets £122m funding for healthcare research

Strategic Developments

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.

IDRM officially opens in Oxford

Strategic Developments

A celebration for the opening of the Institute of Developmental & Regenerative Medicine (IDRM) led by Paul Riley took place on Tuesday 12 July 2022, attended by many DPAG members who have recently relocated to this fantastic new Institute.

NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills

Research Highlights Strategic Developments

Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.

Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment

Research Highlights Strategic Developments

A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.

Unique study of vascular disease reaches 20th anniversary

Research Highlights Strategic Developments

The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.

Load More